Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

Barry A. Borlaug, Michael D. Jensen, Dalane W. Kitzman, Carolyn S.P. Lam, Masaru Obokata, Oliver J. Rider

Research output: Contribution to journalReview articlepeer-review

Abstract

Obesity and heart failure with preserved ejection fraction (HFpEF) represent two intermingling epidemics driving perhaps the greatest unmet health problem in cardiovascular medicine in the 21st century. Many patients with HFpEF are either overweight or obese, and recent data have shown that increased body fat and its attendant metabolic sequelae have widespread, protean effects systemically and on the cardiovascular system leading to symptomatic HFpEF. The paucity of effective therapies in HFpEF underscores the importance of understanding the distinct pathophysiological mechanisms of obese HFpEF to develop novel therapies. In this review, we summarize the current understanding of the cardiovascular and non-cardiovascular features of the obese phenotype of HFpEF, how increased adiposity might pathophysiologically contribute to the phenotype, and how these processes might be targeted therapeutically.

Original languageEnglish (US)
Pages (from-to)3434-3450
Number of pages17
JournalCardiovascular research
Volume118
Issue number18
DOIs
StatePublished - Dec 1 2022

Keywords

  • Adiposity
  • HFpEF
  • Heart failure
  • Inflammation
  • Obesity
  • phenotype

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets'. Together they form a unique fingerprint.

Cite this